TreeFrog Therapeutics
Created in 2018
Up & running (A)
Existing signals show a regular activitySocial networks
913 21,599Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 179
SIREN
343619102Engaged catalyst
51
0 0Added in Motherbase
5 years, 7 months ago
Value proposition
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivationOriginal language
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
https://treefrog.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Not capitalistic Partnership Event 17 Nov 2021 | | |
 Région Nouvelle-Aquitaine National and local authorities, Government Administration | Région Nouvelle-Aquitaine National and local authorities, Government Administration | Other 8 Dec 2021 17 Dec 2024 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 24 Apr 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 6 Dec 2021 3 Oct 2024 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Not capitalistic Partnership Event 26 Nov 2024 | | |
 SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 8 Oct 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 22 May 2024 | | |
 Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 13 Oct 2022 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 13 Jan 2022 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 3 Sep 2022 | | |